Summary
Serum immunoreactive insulin extracted with acid ethanol (total IRI) and blood glucose were measured in two groups of diabetics and a control group during 24-hour periods. One group of diabetics had received insulin for less than 1 month, and none had yet developed insulin antibodies. The other had been treated with insulin for 2 years or more. The average level of total IRI in the diabetics without antibodies was similar to that in the normals, but highly elevated in diabetics with antibodies, although the blood glucose levels were similar in the two diabetic groups. The increase in total IRI after the insulin injections was more rapid in patients receiving quick-acting insulin and most pronounced in those with the highest levels of total IRI. The total IRI peaked in the afternoon and dropped during the night. The short-term insulin-treated patients showed a better degree of diabetes control than those treated for 2 years or more. No correlation was found however, between the total IRI level and the degree of control in the latter group. The patients with the highest levels of total IRI had the highest frequency of hypoglycemic episodes. This is in agreement with the concept that the insulin antibodies may function as a circulating depot, which releases insulin irrespective of the metabolic need.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Belmonte, M. M., Colle, E., DeBelle, Murthy, D. Y. N.: Variability of NPH insulin preparations. Canad. med. Ass. J. 104, 133–138 (1971)
Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, M. A., Newerly, K.: Insulin-I131 metabolism in human subjects: Demonstration of insulin binding globulin in the circulation of insulin treated subjects. J. clin. Invest. 35, 170–190 (1956)
Berson, S. A., Yalow, R. S.: Studies with insulin-binding antibody. Diabetes 6, 402–407 (1957)
Berson, S. A., Yalow, R. S.: Isotopic tracer in the study of diabetes. In Lawrence, J. H. and Tobias, C. A., (Eds.): Advances in biological and medical physics, New York City: Academic Press Inc. Vol. 6, 349–430 (1958)
Berson, S. A., Yalow, R. S.: Quantitative aspects of the reaction between insulin and insulin-binding antibody. J. clin. Invest. 38, 1996–2016 (1959)
Binder, C.: Absorption of injected insulin. Thesis, Copenhagen (1969)
Block, M. B., Mako, M. E., Steiner, D. F., Rubenstein, A. H.: Circulating C-peptide immunoreactivity. Diabetes 21, 1013–1026 (1972)
Christiansen, Aa.H.: Radioimmunoelectrophoresis in the dermination of insulin-binding to IgG. Horm. Metab. Res. 5, 147–154 (1973)
Chu, P.-C., Conway, M. J., Krouse, H. A., Goodner, C. J.: The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann. intern. Med. 68, 757–769 (1968)
Deschamps, I., Heilbronner, J., Lestradet, H., Canivet, J.: Les variations de l'insuline chez le sujet normal au cours de nycthémere. Ann. Endocr. (Paris) 30, 589–594 (1969)
Dixon, K., Exon, P. D., Hughes, H. R.: Insulin antibodies in aetiology of labile diabetes. Lancet. 1972, I, 343–347
Galloway, J. A., Root, M. A., Rathmacher, R. P., Carmichael, R. H.: A comparison of acid regular and neutral regular insulin. Diabetes 22, 471–479 (1973)
Ginsberg, S., Block, M. B., Mako, M. E., Rubenstein, A. H.: Serum insulin levels following administration of exogenous insulin. Endocrinol. Metab. 36, 1175–1179 (1973)
Hansen, Aa. P., Johansen, K.: Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics. Diabetologia 6, 27–33 (1970)
Harwood, R.: Insulin-binding antibodies and “spontaneous” hypoglycemia. New Engl. J. Med. 262, 978–979 (1960)
Heding, L. G.: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8, 260–266 (1972)
Johansen, K.: Endogenous plasma insulin in a juvenile diabetic after ten years of insulin therapy. Arch. intern. Med. 127, 139–140 (1971)
Malherbe, C., Gasparo, M. de, Hertogh, R. de, Hoet, J. J.: Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia 5, 397–404 (1969)
Martin, F. I. R., Russell, J.: A simple method for determining plasma insulin in the presence of endogenous insulin antibodies. Diabetologia 10, 93–96 (1974)
Menzel, R., Michaelis, D., Neumann, I., Schultz, B., Wilke, W., Wulfert, R., Michael, R., Bibergeil, H.: Remission phase in newly diagnosed insulin treated juvenile diabetes: Behaviour of glucose, FFA, HGH and Total-IRI during combined glucose arginine infusion; Development of antibodies against exogenous insulin. Endokrinologie 62, 100–106 (1973)
Metz, R., Bowers, M.: Serum insulin in insulin-treated diabetics. Diabetes 20, Suppl. 1, 368 (1971)
Metz, R., Bowers, M.: Plasma insulin, glucose and free fatty acid relationships in insulin-treated diabetics. Diabetes 21, Suppl. 1, 325 (1972)
Molnar, G. D., Taylor, W. F., Langworthy, A. L.: Plasma immunoreactive insulin patterns in insulin-treated diabetics. Mayo Clin. Proc. 47, 709–719 (1972)
Moxness, K. E., Molnar, G. D., Taylor, W. F., Owen, C. A., Ackerman, E., Rosevear, J. N.: Studies of diabetic instability. I. Immunoassay of human insulin in plasma containing antibodies to pork and beef insulin. Metabolism 20, 1074–1082 (1971)
Munkgaard Rasmussen, S., Parbst, E., Vølund, Aa.: Comparison of the Hagedorn-Jensen and the glucose oxidase method for blood glucose determination. Fifth Annual Meeting of the Scandinavian Society for the Study of Diabetes, 1969. Diabetologia 5, 429 (1969)
Nakagawa, S., Suda, N., Kudo, M., Kawasaki, M.: A new type of hypoglycyemia in a newborn infant. Diabetologia 9, 367–375 (1973)
Pal, S., Gupta, N. N., Mehrotra, R. M. L., Sircar, A. R., Chaturved, K. G.: Insulin antibodies in diabetes mellitus. Indian. J. med. Res. 57, 573–578 (1969)
Quickel, K. E., Feldman, J. M.: Serum-insulin levels in patients on insulin. Lancet 1971 II, 212
Rigas, A. N., Bittles, A. H., Hadden, D. R., Montgomery, D. A. D.: Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycemic agents in diabetes mellitus. Brit. med. J. 1968 IV, 25–28
Schlichtkrull, J., Munck, O., Jersild, M.: The M-value, an index of blood sugar control in diabetics. Acta med. scand. 177, 95–102 (1965)
Schlichtkrull, J., Brange, J., Christiansen, Aa. H., Hallund, O., Heding L. G., Jørgensen, K. H.: Clinical aspects of insulin-antigenicity. Diabetes 22, suppl. 2, 649–656 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Munkgaard Rasmussen, S., Heding, L.G., Parbst, E. et al. Serum IRI in insulin-treated diabetics during a 24-hour period. Diabetologia 11, 151–158 (1975). https://doi.org/10.1007/BF00429840
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429840